OneSource, a TPG Growth-backed specialty pharma CDMO, is in talks with investors to raise $200 million. The company, formerly Stelis Biopha...

Strides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 2854.19 Crore) operating in Pha...

Revenue from operations of the company stood at Rs 688.36 crore for the quarter under consideration. It was Rs 781.79 crore for the same pe...

The company had posted a net profit of Rs 92.33 crore for the corresponding period of the previous fiscal, Strides Pharma Science said in a...

The company had posted a net profit of Rs 25.36 crore in the corresponding period of the previous fiscal, Strides Pharma Science said in a ...

A total of 182,073 shares changed hands on the counter till 10:45AM (IST).

The company's consolidated revenue from operations stood at Rs 618.64 crore for the quarter under consideration.

The consolidated income of the company increased to Rs 744.66 crore in the Oct-Dec period.

Consolidated revenue from operations of the company stood at Rs 794.50 crore.

The observations are not material in nature, the company said.

Consolidated revenue from operations stood at Rs 663.46 crore for the quarter under review.

The generic Ibuprofen capsules, 200 mg, is meant for relieving pain and will be manufactured at the company's oral dosage facility in Banga...

The company had posted a net profit after taxes and minority interest and share of loss of associates and joint ventures of

Strides Shasun today got CCI's approval to acquire Sun Pharmaceutical's two business divisions in India for Rs 165 crore.

"Ranbaxy integration has been a challenge. Things will fall in place. Sun Pharma at current level is good"

Net sales of the company rose to Rs 161.34 crore for the first quarter, as against Rs 120.42 crore in the same period of last year.

Drug firm Strides Arcolab reported a 10.55 per cent dip in consolidated net profit to Rs 61.19 crore for the fourth quarter ended December ...